These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15201352)

  • 1. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency.
    Tomer R; Aharon-Peretz J
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):972-5. PubMed ID: 15201352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered striatal circuits underlie characteristic personality traits in Parkinson's disease.
    Ishii T; Sawamoto N; Tabu H; Kawashima H; Okada T; Togashi K; Takahashi R; Fukuyama H
    J Neurol; 2016 Sep; 263(9):1828-39. PubMed ID: 27334907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personality traits in young patients with Parkinson's disease.
    Jacobs H; Heberlein I; Vieregge A; Vieregge P
    Acta Neurol Scand; 2001 Feb; 103(2):82-7. PubMed ID: 11227136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-related personality traits in Parkinson's disease.
    Menza MA; Golbe LI; Cody RA; Forman NE
    Neurology; 1993 Mar; 43(3 Pt 1):505-8. PubMed ID: 8450991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
    Maril S; Hassin-Baer S; Cohen OS; Tomer R
    Neuropsychologia; 2013 Apr; 51(5):818-24. PubMed ID: 23422331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
    Bódi N; Kéri S; Nagy H; Moustafa A; Myers CE; Daw N; Dibó G; Takáts A; Bereczki D; Gluck MA
    Brain; 2009 Sep; 132(Pt 9):2385-95. PubMed ID: 19416950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dopamine loss differentially affects effort to maximize gain or minimize loss.
    Porat O; Hassin-Baer S; Cohen OS; Markus A; Tomer R
    Cortex; 2014 Feb; 51():82-91. PubMed ID: 24267688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of personality on the alcohol withdrawal syndrome intensity: a preliminary study with the Cloninger's model].
    Coton X; Pinto E; Reggers J; Hansenne M; Parent M; Ansseau M
    Encephale; 2007; 33(3 Pt 1):264-9. PubMed ID: 17675922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological and emotional correlates of personality traits in Parkinson's disease.
    Koerts J; Tucha L; Leenders KL; Tucha O
    Behav Neurol; 2013 Jan; 27(4):567-74. PubMed ID: 23242356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease.
    Kaasinen V; Aalto S; Någren K; Rinne JO
    Mov Disord; 2004 Nov; 19(11):1348-51. PubMed ID: 15389994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality traits in patients with Parkinson's disease: assessment and clinical implications.
    Poletti M; Bonuccelli U
    J Neurol; 2012 Jun; 259(6):1029-38. PubMed ID: 22083431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personality traits and brain dopaminergic function in Parkinson's disease.
    Kaasinen V; Nurmi E; Bergman J; Eskola O; Solin O; Sonninen P; Rinne JO
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13272-7. PubMed ID: 11687621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease, personality, and dopamine.
    Menza MA; Forman NE; Goldstein HS; Golbe LI
    J Neuropsychiatry Clin Neurosci; 1990; 2(3):282-7. PubMed ID: 2136087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.
    Lhommée E; Boyer F; Wack M; Pélissier P; Klinger H; Schmitt E; Bichon A; Fraix V; Chabardès S; Mertens P; Castrioto A; Kistner A; Broussolle E; Thobois S; Krack P
    Mov Disord; 2017 Aug; 32(8):1191-1200. PubMed ID: 28643887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms.
    Meira B; Lhommée E; Schmitt E; Klinger H; Bichon A; Pélissier P; Anheim M; Tranchant C; Fraix V; Meoni S; Durif F; Houeto JL; Azulay JP; Moro E; Thobois S; Krack P; Castrioto A;
    J Parkinsons Dis; 2022; 12(5):1665-1676. PubMed ID: 35527563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality in essential tremor: further evidence of non-motor manifestations of the disease.
    Chatterjee A; Jurewicz EC; Applegate LM; Louis ED
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):958-61. PubMed ID: 15201349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality and Parkinson's disease: A meta-analysis.
    Santangelo G; Garramone F; Baiano C; D'Iorio A; Piscopo F; Raimo S; Vitale C
    Parkinsonism Relat Disord; 2018 Apr; 49():67-74. PubMed ID: 29358028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novelty seeking in patients with right- versus left-onset Parkinson disease.
    Harris E; McNamara P; Durso R
    Cogn Behav Neurol; 2015 Mar; 28(1):11-6. PubMed ID: 25812126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.